| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 108.9MM | -2% |
| Gross Profit | 78.3MM | -4% |
| Cost Of Revenue | 30.6MM | +2% |
| Operating Income | 5.7MM | -2% |
| Operating Expenses | 72.6MM | - |
| Net Income | 9.3MM | - |
| G&A | 39.9MM | -3% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Coty (NYSE:COTY) and the best and worst performers in the personal care industry.
Nature's Sunshine Products' (NASDAQ:NATR) stock is up by a considerable 16% over the past three months. We wonder if...
Looking back on personal care stocks' Q4 earnings, we examine this quarter's best and worst performers, including Nature's Sunshine (NASDAQ:NATR) and its peers.
It's been a good week for Nature's Sunshine Products, Inc. ( NASDAQ:NATR ) shareholders, because the company has just...
Shares of wellness products company Nature’s Sunshine Products (NASDAQ:NATR) jumped 22.7% in the morning session after the company reported fourth quarter results that blew past analysts' EPS expectations. We were also excited its operating margin outperformed Wall Street's estimates. On the other hand, its revenue unfortunately missed, but we still think this was a really good quarter that should please shareholders, especially considering its full-year 2024 EBITDA guidance topped Wall Street's
Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Q4 2023 Earnings Call Transcript March 12, 2024 Nature’s Sunshine Products, Inc. beats earnings expectations. Reported EPS is $0.45, expectations were $0.15. NATR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone. And […]
Robust Sales and Net Income Surge Highlight NATR's Financial Strength
Wellness products company Nature’s Sunshine Products (NASDAQ:NATR) fell short of analysts' expectations in Q4 FY2023, with revenue up 6% year on year to $108.9 million. On the other hand, the company's outlook for the full year was close to analysts' estimates with revenue guided to $467.5 million at the midpoint. It made a non-GAAP profit of $0.45 per share, improving from its profit of $0.10 per share in the same quarter last year.
- Fourth Quarter GAAP Net Income More Than Triples to $9 Million, Adjusted EBITDA up 21% to $9.7 Million - LEHI, Utah, March 12, 2024 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (“Nature’s Sunshine” and/or the “Company”), a leading natural health and wellness company of premium-quality herbal and nutritional products, reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights vs. Same Year-Ago Quarter